Evogene

^{Priced, NYSE: EVGN}

Develops genetically enhanced seeds to elevate crop performance and productivity.

Industry: Health Care

First Day Return: +16.8%

EVGN

Develops genetically enhanced seeds to elevate crop performance and productivity.

IPO News for Evogene

US IPO Recap: Chinese IPOs continue their strong run 11/25/13
Evogene prices IPO at $14.75, below expectations 11/21/13
10 US IPOs planned for the week of Nov 18 11/18/13

IPO Data
IPO Date	11/20/2013
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$74
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.evogene.com
Headquarters	Rehovot, Israel
Founded	2000
Employees at IPO	188

IPO News for Evogene

US IPO Recap: Chinese IPOs continue their strong run 11/25/13
Evogene prices IPO at $14.75, below expectations 11/21/13
10 US IPOs planned for the week of Nov 18 11/18/13

Evogene (EVGN) Performance